Concourse Financial Group Securities, Inc. Bio N Tech Se Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 166 shares of BNTX stock, worth $18,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166
Previous 166
-0.0%
Holding current value
$18,676
Previous $15,000
13.33%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$931 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$539 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$493 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$329 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$213 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.3B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...